Diffuse Cutaneous Systemic Sclerosis - 23 Studies Found

Active, not recruiting : A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
: Diffuse Cutaneous Systemic Sclerosis
: 2014-06-03
:
  • Drug: Abatacept Subjects will

Completed : Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
: Early Diffuse Cutaneous Systemic Sclerosis
: 2014-12-22
:
  • Drug: Methotrexate Immunosuppr
Recruiting : Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis
:
  • Scleroderma, Diffuse
  • Diffuse Cutaneous Systemic Sclerosis

    • : 2015-06-30
    :
    • Drug: IVA337 Capsules of 200mg
Active, not recruiting : Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis
: Diffuse Cutaneous Systemic Sclerosis
: 2015-06-04
:
  • Drug: JBT-101 JBT-101 5 mg q a
Completed : Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
: Systemic Sclerosis
: 2012-08-15
: Drug: Belimumab Belimumab (Benlysta®) decreases B-Cell survival and has been FDA approved for the t
Completed : Mycophenolate Mofetil in Systemic Sclerosis
: Diffuse Cutaneous Systemic Sclerosis
: 2007-02-07
: Drug: Mycophenolate Mofetil Mycophenolate 3000 mg each day
Completed : AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis
: Systemic Sclerosis
: 2008-10-07
:
  • Drug: Hyperimmune caprine serum

Not yet recruiting : Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
: Scleroderma, Systemic
: 2017-01-31
:
  • Drug: GSK2330811 GSK2330811 wi
Withdrawn : A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
: Scleroderma
: 2015-10-26
:
  • Drug: BMS-986020
  • Other: Placebo
Recruiting : Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
:
  • Scleroderma, Diffuse
  • Scleroderma, Systemic
  • Scleroderma, Li
    : 2016-02-08
    :
    • Drug: Oral Ifetroban Subjects

Next >>>